You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chidamide

Showing 151 - 157 of 157
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, T-Cell, Peripheral Trial (Romidepsin, Pralatrexate)

Withdrawn
  • Lymphoma, T-Cell, Peripheral
  • (no location specified)
Dec 17, 2018

Lymphoma, Extranodal NK-T-Cell, EBV Trial (Chidamide BIW, Chidamide QD)

Unknown status
  • Lymphoma, Extranodal NK-T-Cell
  • EBV
  • Chidamide BIW
  • Chidamide QD
  • (no location specified)
Aug 22, 2016

Peripheral T Cell Lymphoma Trial (Chidamide with ICE regimen)

Unknown status
  • Peripheral T Cell Lymphoma
  • Chidamide with ICE regimen
  • (no location specified)
Aug 2, 2016

Non-Hodgkin's Lymphoma Trial in Japan (HBI-8000)

Completed
  • Non-Hodgkin's Lymphoma
  • Aichi, Japan
  • +7 more
Jan 10, 2017

Advanced EGFR-TKI-resistant NSCLC Trial (Chidamide with EGFR-TKI)

Unknown status
  • Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer
  • Chidamide with EGFR-TKI
  • (no location specified)
Jun 23, 2016

Lymphoma, Extranodal NK-T-Cell Trial in Chengdu (GLIDE)

Unknown status
  • Lymphoma, Extranodal NK-T-Cell
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Nov 6, 2017

Non-small-cell Lung Cancer Trial in China (Chidamide, Paclitaxel, Carboplatin)

Completed
  • Non-small-cell Lung Cancer
  • Chidamide
  • +3 more
  • Beijing, Beijing, China
  • +7 more
Jan 28, 2016